Ibex innovations

About Ibex innovations

Ibex Innovations is a UK-based company founded in 2010 that develops advanced medical imaging software to enhance diagnostic capabilities. Initially focused on broad X-ray image enhancement, the company has since pivoted to concentrate primarily on its IBEX Bone Health (BH) technology, which enables the early detection of osteoporosis from routine X-ray images. This software can be integrated with existing and new X-ray and mammography equipment, allowing healthcare providers to opportunistically screen for low bone mineral density without requiring separate, dedicated machinery.

The company was founded by Gary Gibson and later joined by CEO Dr. Neil Loxley in 2012 to commercialize the technology. Its current CEO is Dr. Paul Scott. The firm's core products, including IBEX Trueview® and IBEX BH, utilize a combination of physics and artificial intelligence to analyze standard X-rays, providing clearer images and quantitative data on bone mineral density. This technology aims to address the significant underdiagnosis of osteoporosis, a condition that often remains undetected until a fracture occurs. By facilitating earlier diagnosis, Ibex helps to reduce fracture risk and healthcare costs.

Ibex Innovations operates on a business-to-business model, partnering with original equipment manufacturers (OEMs) of medical imaging systems. The company has secured deals with international manufacturers like US-based Curvebeam, Finnish company Planmed, and Italy's Metaltronica to integrate its software into their devices. It also has a major partnership with Agfa Radiology Solutions, whose DensityScan™ workflow is powered by IBEX BH technology. The company is backed by venture capital and corporate investors, including IP Group, Mercia, and Northstar Ventures, and has received grants from InnovateUK and the European Union's Horizon 2020 programme. Headquartered at NETPark in Sedgefield, UK, Ibex maintains strong collaborations with several universities and NHS Trusts.